If you need more lookups,
subscriptions start at $34 USD/month.
Holger Ottleben Location
Germany
Holger Ottleben Work
2026 -now Member of the Scientific Advisory Board @
2025 -now Chairman of the Board @
2024 -now Chairman of the Board @
2019 -now Member of the Advisory Board @
2021 -2024 General Manager and Head Human Pharma, Austria @
2020 -2022 President of the Supervisory Board @
2019 -2022 President of the Supervisory Board @
2018 -2021 Managing Director, Switzerland @
2011 -2020 Member of the Supervisory Board @ Scienion AG
2016 -2018 Member of the Human Pharma Leadership Team Germany @
2013 -2015 Corporate Vice President – Strategy @
2011 -2013 Head of Corporate Strategy and Development and PMO @
2005 -2011 Project Leader @
1998 -2005 CTO and Co-Founder @ Graffinity Pharmaceuticals AG (now Santhera AG)
Holger Ottleben Education
Friedrich-Schiller-Universität Jena 1994-1998
Leibniz Universität Hannover 1988-1994
INSEAD
Duke University
King's College London
Holger Ottleben Skills
Microsoft Office
Customer Service
Management
Project Management
Holger Ottleben Summary
Holger Ottleben, based in Germany, is currently a Member of the Scientific Advisory Board at iBET - Instituto de Biologia Experimental e Tecnológica. Holger Ottleben brings experience from previous roles at Perseo pharma AG, Tridek-One, Wellster Healthtech Group and Boehringer Ingelheim. Holger Ottleben holds a 1994 - 1998 Friedrich-Schiller-Universität Jena. With a robust skill set that includes Microsoft Office, Customer Service, Management, Project Management and more. Holger Ottleben has 1 emails on RocketReach.
Looking for a different Holger Ottleben?
Find contact details for 700 million professionals.
Search
Top iBET - Instituto de Biologia Experimental e Tecnológica Employees